2012
DOI: 10.1016/j.msec.2012.01.021
|View full text |Cite
|
Sign up to set email alerts
|

Poly(3-hydroxyalkanoate)s: Diversification and biomedical applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
124
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 225 publications
(129 citation statements)
references
References 124 publications
1
124
0
Order By: Relevance
“…In particular, the possibility to adjust material properties by controlling the monomeric composition, and functionalize it via introduction of vinyl groups is of great interest 1 . Whereas short-chain-length PHAs (scl-PHA, C4-C5 monomers) are readily available on the market 2,3 , largescale commercialization of mcl-PHA is still to be established.…”
Section: Introductionmentioning
confidence: 99%
“…In particular, the possibility to adjust material properties by controlling the monomeric composition, and functionalize it via introduction of vinyl groups is of great interest 1 . Whereas short-chain-length PHAs (scl-PHA, C4-C5 monomers) are readily available on the market 2,3 , largescale commercialization of mcl-PHA is still to be established.…”
Section: Introductionmentioning
confidence: 99%
“…scaffolding for the regeneration of nerve axons and arteries. Amphiphilic PHA copolymers have significant applications in drug delivery, tissue engineering and cardiovascular area, e.g., artery augments, vascular grafts, cardiologic stents, heart valves, implants, pericardial patches, microparticulate carriers, and dressing tablets 62 . PHB can be degraded to HB identified in high concentration in human blood.…”
Section: Phb Propertiesmentioning
confidence: 99%
“…mcl-PHA with decreased T g is soft and elastic, making it suitable for biomedical applications 62 . The chemical structure and monomer composition are efficiently influence the material and physical characteristics of PHAs 29,87,88 .…”
Section: Copolymers Productionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, polyester nanoparticulate DDSs can be formed from either naturally occurring polymers such as chitosan [41] or PHAs [42][43][44], or from synthetic macromolecules such as PLA, PEG, PCL or PHAs. Indeed, PHAs can be advantageously both naturally (microbial PHAs) or synthetically (chemically) produced [43,[45][46][47][48][49][50][51][52][53][54][55][56][57]. Among the numerous PHAs, the ubiquitous biocompatible and biodegradable poly(3-hydroxybutyrate) (PHB) can be obtained from bacteria as isotactic PHB, while ROP of substituted -lactones provides a valuable entry into PHBs featuring various tunable microstructures (atactic, syndiotactic, isotactic) [58][59][60].…”
Section: Introductionmentioning
confidence: 99%